Cannes Lions

Together Let's End Malaria

SC JOHNSON, Racine / SC JOHNSON / 2024

Awards:

1 Shortlisted Cannes Lions
Case Film
Supporting Content
Case Film

Overview

Entries

Credits

Overview

Background

Malaria is an entirely preventable disease, but has been killing people for thousands of years. Current interventions have limited effectiveness and duration.

The challenges for many solutions are access (rural, hard-to-reach areas are most affected by malaria), maintenance (burners that require constant flame) and power (many rural locations have no, or only very limited, power supplies), while traditional nets are often repurposed for fishing (people choosing between hunger and malaria).

SC Johnson set about creating Guardian™ as a highly innovative, incredibly effective response to these obstacles. Developed with the ambition of delivering the highest levels of protection for the longest duration possible while maintaining consistent levels of effectiveness in the most challenging conditions (high humidity and temperature). Guardian™ was created to get a practical, usable, and highly effective intervention into these households and communities.

Guardian™ is a highly innovative, incredibly effective solution, yet it needs a formal WHO policy recommendation as a public health intervention to reach the millions of people who are most vulnerable and who need it most. Until then, SCJ is working with its partners to distribute Guardian™ as widely as possible.

Idea

Create a film to galvanize policymakers, politicians, members of Congress, NGOs, charities and local government organizations to rally around Guardian™: a simple, low-cost, highly effective and long-lasting spatial repellent. Requiring no power or ongoing maintenance, one Guardian™ protects a whole dwelling from mosquito-borne disease for an entire year.

SC Johnson has committed over $50 million to generate evidence to inform this WHO policy recommendation as a public health intervention. Until that policy is approved, we need a family of partners to get Guardian™ distributed via schools, hospitals, and health clinics in vulnerable communities around the world.

Showcasing and celebrating the effectiveness of Guardian™ and the dramatic reduction of infection rates in communities gives hope that the eradication of malaria is possible, creating a groundswell of energy and, most importantly, support for Guardian™.

Strategy

Eliminate Malaria.

Create a product that would dramatically reduce the infection rates in communities, offering long-term, easy-to-use and highly effective protection from mosquito bites that will protect entire villages, not just individual households.

Utilizing decades of research, product development, experience fighting malaria and SCJ’s purpose to work for a better world, collaborate with scientific institutions, NGOs and charitable foundations to create, trial and prove the effectiveness of a solution to prevent the spread of Malaria.

Create and work with a family of partners to help fund and distribute as many Guardian™ units as possible to the places most at risk from malaria while awaiting WHO recommendation as a public health intervention.

Get approval from the WHO and provide this solution at no cost to the millions of people around the world who are at risk from infection and death.

Execution

In 2013, SCJ formed a dedicated team called ‘Base of the Pyramid Group’ to focus specifically on helping the more than 4 billion people globally that earn less than a few dollars (USD) per day. These communities are in some of the highest risk areas for mosquito-borne diseases. Since then, and in partnership with several scientific and educational institutes, SCJ has continued to push innovation in the field of mosquito protection and malaria prevention, particularly spatial repellents.

Guardian™ is the culmination of over a decade of work. Made from 3D mesh fabric enclosed in a PET cage that is hermetically sealed in a pouch and stable over time at elevated temperatures and humidity. Simple to use, accessible to all and highly effective. Trials have taken place in several African countries, particularly in hard-to-reach remote areas.

To date, 1M+ people have been protected by Guardian™ & Mosquito Shield.

Outcome

Each Guardian™ unit is capable of reducing instances of mosquito bites by 91%. The impact on rural communities at risk from malaria is huge.

Currently, Guardian™ is awaiting WHO approval for use as an official public health intervention. If granted, this would be the first new intervention recommended in the malaria prevention space in 25 years.

1M+ people protected by Guardian™ & Mosquito Shield™ to date

A demonstrated 91% reduction in instances of mosquito bites

$2 Billion Funds Advocated to Grow Malaria Programs Administered by Global Fund

$100 Million+ funding committed by SCJ and partners to generate evidence to inform a WHO policy recommendation

$30 Million committed funding by SC Johnson for spatial repellent production in Kenya

147 Congressional offices visited

5 New Partnerships Established: The Global Fund, United Nations Foundation, Kenya Ministry of Health, Tanzania Ministry of Health, Jakaya Mrisho Kikwete Foundation

Creation of 150+ jobs in Nairobi

Similar Campaigns

12 items

Welcome to Womandhood

MEMAC OGILVY, Dubai

Welcome to Womandhood

2023, DOVE

(opens in a new tab)